IRINOTECAN INTAS irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial

Страна: Австралія

мова: англійська

Джерело: Department of Health (Therapeutic Goods Administration)

Активний інгредієнт:

irinotecan hydrochloride trihydrate, Quantity: 40 mg

Доступна з:

Accord Healthcare Pty Ltd

ІПН (Міжнародна Ім'я):

irinotecan hydrochloride trihydrate

Фармацевтична форма:

Injection, concentrated

Склад:

Excipient Ingredients: water for injections; sodium hydroxide; hydrochloric acid; sorbitol; lactic acid

Адміністрація маршрут:

Intravenous Infusion

Одиниць в упаковці:

1 vial

Тип рецепту:

(S4) Prescription Only Medicine

Терапевтичні свідчення:

Irinotecan hydrochloride is indicated as a component of first-line therapy for patients with metastatic carcinoma of the colon or rectum. Irinotecan hydrochloride is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

Огляд продуктів:

Visual Identification: A pale yellow clear solution; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Статус Авторизація:

Licence status A

Дата Авторизація:

2014-06-12